Medtronic Appoints 20-Year Veteran Sean Haag as President of ENT Business

On March 10, 2026, Medtronic, a global leader in medical technology, announced,Appointed Sean Haag as the President of its Ear, Nose, and Throat (ENT) business.Haag will take full leadership of the ENT business while joining the Neuroscience Portfolio Leadership Team.

Notably, Medtronic's ENT (Ear, Nose, and Throat) business is a crucial component of the company’s neuroscience portfolio. With its strong expertise in key areas such as image-guided surgery, intraoperative neural monitoring, and powered surgical instruments, Medtronic has established itself as a global leader in the ENT market.

Medtronic ENT New President Sean Haag

Haag is no stranger to Medtronic's ENT business, having served as the interim president of the business since July 2025.During his interim tenure, he demonstrated exceptional leadership, not only strengthening the leadership team and deepening key customer relationships but also driving significant business growth. This formal appointment fully reflects the company's high recognition of the strong development momentum of the ENT business and his leadership capabilities.

Haag has nearly 30 years of experience in the medical industry, including over 20 years at Medtronic.With a deep understanding of the company culture and business. Before serving as interim president, he was the Vice President of Marketing and Clinical for Medtronic’s AiBLE ecosystem, with precise insights into market dynamics and customer needs.

Sean Haag Work Experience

Brett Wall, President and Executive Vice President of Medtronic's Neuroscience Portfolio, expressed high hopes for this appointment: "Sean is a highly strategic and people-oriented leader who has built deep trust with his teams and customers while driving performance. He led the ENT business with clarity of thought and disciplined leadership during a transformative period. His profound understanding of the market, portfolio, and customers positions him to guide the team into the next phase of growth in an increasingly dynamic and competitive environment."

Regarding the new appointment, Haag stated: "I am honored to continue leading the ENT department and working with such a talented and dedicated team. Our business plays a crucial role in improving the lives of nearly 3 million patients each year. I am excited to build on the progress we have made, accelerate innovation, strengthen collaboration, and deliver tangible impacts for patients worldwide."